FDANews
www.fdanews.com/articles/190293-nuvasives-magnetic-implant-system-nabs-dual-clearance
NuVasive_Logo.gif

NuVasive’s Magnetic Implant System Nabs Dual Clearance

February 20, 2019

NuVasive’s Precice bone transport system has received both 510(k) clearance and the CE Mark for use in segmental bone loss treatment.

The Precice system is part of the company’s NuVasive Specialized Orthopedics family of magnetically adjustable, limb-lengthening implants.

The magnetic implant can treat complex segmental defects in the tibia and femur caused by trauma or infection and allows patients to avoid many complications from external fixation systems.

View today's stories